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Abstract
Objectives
Eliminating unnecessary laboratory tests is a good way to reduce costs while maintain patient
safety. The aim of this study was to define and process strategies to rationalize laboratory use in
Ankara Numune Training and Research Hospital (ANH) and calculate potential savings in costs.
Methods
A collaborative plan was defined by hospital managers; joint meetings with ANHTA and lab-
oratory professors were set; the joint committee invited relevant staff for input, and a labora-
tory efficiency committee was created. Literature was reviewed systematically to identify
strategies used to improve laboratory efficiency. Strategies that would be applicable in local
settings were identified for implementation, processed, and the impact on clinical use and
costs assessed for 12 months.
Results
Laboratory use in ANH differed enormously among clinics. Major use was identified in inter-
nal medicine. The mean number of tests per patient was 15.8. Unnecessary testing for chlo-
ride, folic acid, free prostate specific antigen, hepatitis and HIV testing were observed. Test
panel use was pinpointed as the main cause of overuse of the laboratory and the Hospital
Information System test ordering page was reorganized. A significant decrease (between
12.6–85.0%) was observed for the tests that were taken to an alternative page on the com-
puter screen. The one year study saving was equivalent to 371,183 US dollars.
Conclusion
Hospital-based committees including laboratory professionals and clinicians can define
hospital based problems and led to a standardized approach to test use that can help clini-
cians reduce laboratory costs through appropriate use of laboratory tests.
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Introduction
Reducing healthcare costs, with the maintainance of patient safety and improved quality, is one
of the main targets in most healthcare reform efforts. It is often difficult to decide how to
achieve this goal. Eliminating unnecessary laboratory tests and procedures is one good place to
start. It has been reported that approximately $6.8 billion of medical care in the United States
has involved unnecessary testing and procedures that do not improve care and may even harm
the patient [1]. The American Society for Clinical Pathology dedicated their April 2012 edition
of Critical Values to the issue of appropriate laboratory testing, and pointed out the aim as
‘‘right test, right patient, right time, at the right cost” [2].
It is important to prioritise hospital-based strategies to reduce healthcare costs. ANHTA is
the first hospital based Health Technology Assessment (HTA) Unit in Turkey. The unit aims
to support hospital managers in evidence-based investment or disinvestment decisions regard-
ing health technology use in the hospital. Hospital based committees, including laboratory pro-
fessionals and clinicians, can define hospital based problems, which can lead to standardized
approaches. Hospital based HTA units have a crucial role in working with the related profes-
sionals to facilitate an evidence-based approach in the process, which would further lead to
improved quality with reduced costs.
In this study, our aim was to define and process strategies to rationalize laboratory use in
Ankara Numune Training and Research Hospital (ANH) and calculate impact and potential
savings in health-care costs.
Methods
A collaborative action plan was defined by the hospital managers. Joint meetings with ANHTA
and laboratory chairs were set; the joint committee invited relevant staff for input, and hospital
laboratory efficiency committee was created, including clinicians from internal medicine, gen-
eral surgery, family medicine, emergency department and the laboratory directors of biochem-
istry and microbiology departments. Literature was reviewed in order to identify strategies
used to improve laboratory efficiency. Strategies that would be applicable in local setting were
identified for implementation, processed and impact on clinical use and costs was assessed for
12 months.
Implementations were decided and processed as detailed below:
Taking a picture about the current status and increasing the awareness
1. A hospital meeting was conducted in order to create an awareness and the doctors from var-
ious departments were informed about the appropriate use of laboratory tests. The examples
of the overused tests were shared and discussed during the meetings. The impact of the labo-
ratory costs, the potential harms of ordering an unnecessary test for a patient, the impor-
tance of increasing the clinician-laboratory interaction was emphasized.
2. A follow up procedure was planned and a laboratory use report, including mean number of
ordered tests per patient and total laboratory cost of every department was prepared. Labo-
ratory use reports were sent to the departments every month.
3. A review was performed to understand how various laboratory tests were used and whether
the use was appropriate according to the guidelines or evidence provided in the literature.
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Literature search about evidence based laboratory practices and
identification of strategies that would be applicable in local setting
4. Literature was reviewed in order to identify strategies used to improve laboratory effi-
ciency and the implementations reported in the literature were listed. Although a formal
systematic review was not undertaken as this was outside the scope of this study, our pri-
mary objective was to identify any relevant information related to the objective of our
study. We looked for systematic reviews and health technology assessment reports as well
as any trials that would provide additional information about techniques to improve labo-
ratory use. We searched PubMed and the Cochrane Library, using “(laboratory test) AND
(misuse OR overuse)” as search terms. The databases of health technology assessment
agencies were manually searched for relevant references. We also searched for relevant
citations from the articles we initially selected, to locate any additional studies of interest.
The inclusion criteria were systematic reviews/reviews/randomized controlled trials/HTA
reports (Study Design) of interventions/strategies (Intervention) to reduce the misuse or
abuse of laboratory tests (Outcome) ordered by physicians in hospital settings (Popula-
tion/Problem). Two researchers reviewed all relevant papers to identify different tech-
niques and interventions to affect laboratory use and summarized their findings.
5. After the review of techniques, the barriers which can block the process during imple-
mentation and possible solutions were discussed by the committee.
Monitoring of the effects and evaluation of the economic impact
6. The number of ordered tests and total laboratory costs of the hospital were followed for
one year by monitoring the laboratory test amount, between March 2013-March 2014.
Numbers of the ordered tests were compared with the previous year numbers for every
month. The amount of this decrease was calculated as the Reduction% (R% = [(Sum of
the tests between March 2012-March 2013)- (Sum of the tests in March 2013-March
2014)/(Sum of the tests between March 2012-March 2013)]100). The total impact was
calculated at the end of the one-year-follow up period.
Results
This study was run in ANH, which is in service in Ankara, Turkey since 1881. ANH is a refer-
ence hospital with great experience in research and training. It has 1200 bed capacity and ser-
vice is provided by over 5000 staff. Health care services run in 38 different specialties; and
residency trainings are given in 31 specialties. It had 218.866.322 TL budget in 2013 and
235.398.498 in 2014 (over 80 million euros per year in average). Outpatient admissions were
962.589 patients in 2013 and 1.013.300 patients in 2014. Highest number of admissions were to
internal medicine and emergency departments. Overall mortality rate in the hospital during
the year preceding the intervention was 0.028 and was unchanged the following year. Similarly,
the mean (SD) length of hospitalization was 6.2 (0.3) days during the first year and 6.3 (0.2)
during the second year of the study.
Search Results
The literature review through PubMed identified 251 potentially relevant articles. A filter for
systematic reviews revealed 8 and a filter for reviews revealed 27 hits. 12 randomized controlled
trials were also identified. A review of the Cochrane Library revealed 20 trials. No HTA report
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was identified through this search. The manual search of databases of HTA agencies revealed
three related reports. There were 12 overlaps, which left us 58 papers. 42 papers were
excluded through a first overview of titles, ending up with 2 HTA reports, 4 systematic
reviews, 4 reviews, 8 randomised controlled trials and 3 non-randomised trials. Exclusion of
non-relevant papers based on full reading of the papers finally left us 2 HTA reports, 2 sys-
tematic reviews, 4 reviews and 3 trials. Flow diagram and list of the included studies are given
in Fig 1 and Table 1.
The findings were later discussed by the committee to identify which techniques would be
implemented in the local setting.
Techniques use review results. The CADTH reports [3,4] highlighted the utilization of
computerized decision support systems observing that use of such technology improved physi-
cian prescribing behavior. One trial comparing watchful waiting rather than direct ordering of
tests concluded that this was a practical approach to optimize laboratory use. Audit feedback
was also presented as an appropriate strategy for limiting the use of laboratory tests. The
INESSS report [5] suggested the use of Information technology (IT) for decision support algo-
rithms, development of guidelines, modification of prescriber behaviors, and appropriate legis-
lation. Similar use of IT was suggested by Levick et al, whereby computerized alerts (red flags)
could warn the clinicians and the laboratory specialists when certain tests were ordered exces-
sively [6]. Ferraro recommended close collaboration between the physicians ordering tests and
the laboratory personnel providing the services [7]. Organizational strategies including a focus
on Total Quality Management have also been presented as a method to optimize use of labora-
tory services. In one study, the investigators highlighted the role of administrative modifica-
tions such as limiting the availability of certain laboratory services based on their frequency,
education of hospital staff, and feedback to streamline the process [8].
Test use review results. All of the laboratory orders for a three month period were investi-
gated in order to understand the tendencies of the clinicians which might be quite different for
every hospital. Overused (ordered more commonly than expected e.g folic acid, LDH, chloride
orders which have little clinical impact on clinical decision except specific patients) or misused
tests (e.g. HBeAg test order for a HBsAb positive patient, TORCH (toxoplasmosis, rubella,
cytomegalovirus, herpes) IgG and IgM testing for every pregnant women, preoperative hepati-
tis and HIV testing, free PSA testing independent from total PSA levels) were reviewed. During
this review, Na-K-Chloride tests were ordered together in %98.5 of the patients,
GGT-ALP-LDH tests were ordered together in 86% of the patients, total PSA and free PSA
were ordered at the same time in 98% of the patients. The results of the test use review at ANH
showed that major use was in internal medicine. The mean number of tests per patient was
15.8. Laboratory use differed enormously among clinics (5–28 tests per patient). The budget
impact of all tests per year was 4 433 902 $. Overuse of chloride, lactate dehydrogenase, free
PSA (prostate specific antigen), folic acid, hepatitis and HIV tests, and considerable variation
from guideline recommendations for preoperative routine testing were observed. For example
chloride was observed to be ordered as a part of Na-K-Cl electrolyte panel and was ordered for
every patient who had an electrolyte testing. Free PSA was ordered independently from the
total PSA level although it is known to be valuable for only the patients whose total PSA levels
are within the gray zone (2–10 ng/mL). Folic acid was ordered for the majority of patients who
had been tested for Vitamin B12 levels. The reason for the overuse of these tests was thought as
the tendency of the clinicians to order specific tests attached to another (e.g. ordering chloride
with sodium and potassium or folic acid with Vitamin B12). Clinicians were observed to use
test panels which they constitute for quick pick up of the laboratory tests and these panels have
thought to be a major cause of unnecessary testing for ANH.
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Fig 1. Flow diagram showing literature search.
doi:10.1371/journal.pone.0153693.g001
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Strategies decided to be implemented based on consensus of the
committee members
1. Education of the clinicians about evidence based practices [9,10]. This strategy was imple-
mented through hospital internal meetings.
2. Informing clinicians about the laboratory costs [11,12]. A laboratory use report including
mean number of ordered tests per patient and total laboratory cost of every department was
sent to each department every month.
3. The rearrangement of the computerized test ordering page [13]. This rearrangement was
performed for the tests which were detected as overused tests during the use review. Test
ordering page was divided into two separate pages which were in different screens on the
computer and the tests which give less information, ordered more than expected or
observed to be mis-used were taken to the second page.
4. Using test panels during the test order was determined as a major problem causing overuse.
Therefore, the use of the test panels was forbidden, after informing the clinicians.
5. The integration of prompting notes to the computerized test ordering page [14]. We imple-
mented a prompting note to give information when the same test had been ordered within
the previous week.
Table 1. List of the included studies.
HTA Reports
Canadian Agency for Drugs and Technologies in Health Rapid Response Report:. Techniques to improve
the use of diagnostic laboratory test ordering: Clinical Evidence. 12 March 2013.
Canadian Agency for Drugs and Technologies in Health. Health Technology Inquiry Service HTA Report:
Diagnostic Test Ordering: Techniques to improve use. 13 May 2010.
Systematic Reviews
Hauser RG, Shirts BH. Do we now know what inappropriate laboratory utilization is? An expanded
systematic review of laboratory clinical audits. Am J Clin Pathol. 2014; 141(6):774–83.
van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review
of laboratory clinical audits. JAMA. 1998;280(6):550–8.
Reviews
Axt-Adam P, van der Wouden JC, van der Does E. Inﬂuencing behavior of physicians ordering laboratory
tests: a literature study. Med Care. 1993;31(9):784–94.
Smetana GW, Macpherson DS. The case against routine preoperative laboratory testing. Med Clin North
Am. 2003 Jan;87(1):7–40.
Levick DL, Stern G, Meyerhoefer CD, Levick A, Pucklavage D. "Reducing unnecessary testing in a CPOE
system through implementation of a targeted CDS intervention". BMC Med Inform DecisMak. 2013 Apr
8;13:43
Ferraro MJ. Effect of diagnosis-related groups on diagnostic methodology in the hospital laboratory.
DiagnMicrobiol Infect Dis. 1986;4:135S-142S.
Trials
Calderon-Margalit R, Mor-Yosef S, Mayer M, Adler B, Shapira SC. An administrative intervention to
improve the utilization of laboratory tests within a university hospital. Int J Qual Health Care. 2005 Jun;17
(3):243–8.
Wong ET, McCarron MM, Shaw ST Jr. Ordering of laboratory tests in a teaching hospital. Can it be
improved? JAMA. 1983 Jun 10;249(22):3076–80.
Isouard G. A quality management intervention to improve clinical laboratory use in acute myocardial
infarction. Med J Aust. 1999 Jan 4;170(1):11–4
doi:10.1371/journal.pone.0153693.t001
Impact of Laboratory Test Use Strategies in a Turkish Hospital
PLOS ONE | DOI:10.1371/journal.pone.0153693 April 14, 2016 6 / 11
Monitoring and impact evaluation
We started to implement the defined strategies by February 2013. The first strategy of the
above was implemented in February while the rest of the strategies were implemented by
March 2013. We did not follow the the impact of the strategies separately in order not to
extend the following time. We aimed to obtain a maximum impact with the combination
of the five strategies. The impact on laboratory use and costs were monitored with the
follow up of the test numbers and impact was evaluated for the following 12 months after
March 2013. There was a significant decrease in the number of the tests after the decided
interventions.
All of the panels involving electrolyte testing included Na-K-Chloride tests independent
from the diagnosis, although chloride test is recommended to be used in specific conditions
[15]. After prohibition of the panels, the chloride test was moved to the second test ordering
page, which inhibited the quick-pick of the test and a reduction of 51.3% was observed. The
same strategy provided a 44.2% reduction for free PSA and 67.7% reduction for folic acid. The
reason for overuse of these tests just seemed to be an ordering habit without a significant scien-
tific reason, and separation of Cl from Na-K, folic acid from vitamin B12 and free PSA from
total PSA was thought to decrease this kind of use.
A significant overuse in ordering of TORCH (IgG antibodies measured by ELISA against
toxoplasmosis, rubella, cytomegalovirus, herpes) testing has been observed during the use
review. Moving these tests to the second page resulted in reduction of 78.9%, 85.0% and
79.8%, respectively for IgG antibodies to cytomegalovirus, toxoplasmosis and rubella.
The reason for the overuse of ELISA tests was thought to be related to insufficient medical
knowledge to order and interpret the ELISA tests and further training of residents has been
planned.
The total test numbers of the parameters which were moved to the second page in compari-
son with the previous year’s numbers are given in Table 2. Use of all of the tests which were
moved to the second page decreased significantly (between 12.6–85.0%). The comparison of
the sum of these tests with the previous year is demonstrated in Fig 2. The most significant
decrease was observed in toxoplasmosis IgG at 85,0%. The one year impact of the study was
calculated as a saving of $371 183.
Discussion
This study reflects the first results from an ongoing HTA program on appropriate test use in
ANH. Our one year experience showed that a collaborative plan might have significant effects
in reducing laboratory costs. Although we neither documented and quantified misuse nor for-
mally used benchmarks, our baseline data provided clear signals of overuse of basic laboratory
tests based on the literature search, also supported by variation across hospital units, giving
support to our cost-containment action.
More than half of the clinical decisions have known to be influenced by laboratory results
[16]. Importantly, research reporting a wide variation in laboratory testing behaviour of clini-
cians for similar syndromes has shown no improvement in clinical outcomes with increasing
numbers of tests [17–20].
A variety of studies have been performed with the aim of appropriate use, however most of
them have focused on reducing the use of a limited number of laboratory tests [21–24]. The
results of a similar organizational use management programme have been published recently
and reported that a reduction of 26% in inpatient tests per discharge was managed during a
10-year period [13]. Our results in this study confirmed that hospital committees or organiza-
tions may provide a higher impact than focusing on a limited number of specific tests.
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Table 2. Numbers of tests moved to the second page in the computerized test ordering page during the follow up period and comparison with the
previous year’s numbers. (%R = Percentage of reduction in test numbers).
March April May June July August September October November December January February %R
Number of
Patients
Before 85.808 81.252 84.307 78.261 76.227 68.143 75.434 72.065 83.167 81.791 88.283 87.851
After 90.621 89.720 91.241 80.448 80.238 72.325 81.994 71.821 87.059 90.317 90.412 87.104
Uric Acid Before 12.186 11.460 12.121 11.798 12.157 9.438 10.568 10.240 12.599 11.372 13.375 9.573 42,5
After 6.293 5.670 6.931 6.268 7.052 5.664 6.401 5.432 6899 7.412 7.820 6.921
Lipase Before 706 720 752 715 680 699 645 605 842 593 595 563 75,2
After 179 142 138 138 129 151 145 155 221 211 229 171
Chloride Before 19.806 19.818 21.015 19.668 20.376 19.225 19.701 19.367 20.494 14.861 20.177 16.502 51,3
After 9.491 8.794 10.017 9.484 10.144 8.903 7.988 8.783 8391 10.127 10.678 9.608
LDH Before 15.444 16.257 17.378 16.411 16.789 15.361 15.252 15.343 16.159 11.745 16.672 13.662 29,5
After 10.470 9.819 10.912 10.786 11.272 11.033 10.393 10.295 11122 12.322 12.641 10.432
Pre Albumin Before 499 470 394 448 458 406 425 394 495 506 2.079 723 78,5
After 251 147 176 121 112 123 112 101 116 84 135 94
ASO Before 1.431 1.366 1.510 1.335 1.207 973 1.284 1.155 1.528 1.007 1.092 1.012 48,6
After 635 642 828 634 667 555 745 502 710 586 602 558
RF Before 3.258 2.923 3.342 3.128 2.904 2.225 2.593 2.556 3.282 2.208 2.700 3.174 27,5
After 2.497 2.271 2.518 1.821 1.790 1.714 1.864 1.450 2385 2.058 2.316 2.167
Ig G Before 609 631 706 604 596 485 556 447 649 410 553 534 27,8
After 382 375 390 359 441 411 467 340 473 468 380 408
Ig M Before 596 628 703 608 600 483 555 436 642 400 551 526 29,0
After 378 373 381 359 426 388 457 336 468 451 374 386
Ig A Before 564 599 645 580 557 472 535 418 639 378 547 524 23,1
After 383 377 417 366 446 410 471 348 482 471 395 403
C3 Before 465 430 433 444 397 404 398 318 471 305 427 378 12,6
After 309 332 431 363 382 390 360 233 392 350 456 259
C4 Before 478 445 440 460 406 413 420 339 485 325 449 388 19,7
After 313 330 436 368 371 288 311 224 378 340 443 254
Free PSA Before 1.277 1.226 1.274 1.022 932 782 945 957 1.216 954 1.533 1.241 44,2
After 911 632 600 524 514 455 501 448 714 654 794 704
CA 15–3 Before 1.401 1.354 1.405 1.228 1.209 990 1.276 1.081 1.306 1.065 1.573 1.082 29,7
After 955 917 911 801 892 741 913 668 1020 946 939 819
CA 125 Before 1.320 1.325 1.340 1.137 1.099 928 1.194 967 1.262 960 1.593 1.037 33,8
After 858 818 805 698 839 590 780 532 943 833 822 863
CA 19–9 Before 1.748 1.612 1.613 1.376 1.359 1.172 1.496 1.211 1.624 1.239 1.791 1.386 26,9
After 1.166 1.113 1.081 969 1.126 805 1.152 846 1236 1.113 1.142 1.128
Folic Acid Before 5.756 5.283 5.688 5.406 5.467 4.901 4.906 4.659 5.944 3.659 6.459 3.779 67,7
After 1.472 1.462 1.825 1.678 1.950 1.624 2.055 1.229 1707 1.784 1.781 1.445
Anti TG Ab Before 884 802 780 693 623 729 650 547 836 600 850 669 22,9
After 437 496 561 526 870 612 651 368 516 540 510 588
Anti HBs Before 2.274 2.107 2.224 2.262 2.170 2.053 2.510 1.986 2.608 1.827 1.992 2.201 62,3
After 879 881 964 690 750 670 759 746 895 892 977 772
CMV IgG Before 234 207 213 207 196 277 198 175 232 173 225 208 78,9
After 53 54 41 40 40 37 37 34 46 52 55 48
Toxo IgG Before 342 321 326 318 327 374 331 312 393 282 310 330 85,0
After 70 58 43 39 44 44 44 44 43 65 53 49
Rubella IgG Before 330 220 320 307 313 371 321 299 384 278 306 327 79,8
After 70 59 43 50 46 60 60 46 72 90 89 77
TOTAL Before 71.608 70.204 74.622 70.155 70.822 63.161 66.759 63.812 74.090 65.461 75.849 59.819 38,5
After 43.426 42.200 46.915 42.707 45.820 39.996 41.525 38.208 44.266 41.272 43.631 38.154
doi:10.1371/journal.pone.0153693.t002
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Hospital-specific test use review is an important step to define strategies and decide on
routes. It has been reported that test use behaviour and practice of medical care and tests
might be different according to region and geography [25]. Our initial results showed that cre-
ating a hospital committee and performing a test use review provides important information
about hospital priorities in appropriate test use and these priorities might differ in different
institutions.
Our priority has been identified as prohibition of the clinician test panels because there was
a wide variety between panels which can lead to overuse of the tests.
It is important to emphasize that none of the implementations included a prohibition of the
laboratory test orders for the clinicians. The clinicians were free to order any of the laboratory
tests. However, throughout the course of the study, we welcomed inputs from clinicians caring for
patients, about their perceptions regarding the changes in the preordering format. None of them
reported any difficulties with the modified system. This indirectly reiterates that many of the tests
ordered were perhaps not essential in the first place. Ideally, we would have liked to assess the clin-
ical impact of the modified system in terms of clinical outcomes such as mortality rate, morbidity
rates, length of hospitalizations, requirement for enhanced monitoring etc; in order to confirm
that patient care was not compromised. However, this was outside the scope of this study. It can
be argued that the time of clinicians caring for patients may be increased by having to order lab
tests sequentially rather than together. This could theoretically increase costs based on clinician
time. However, we have not calculated costs based on this. Informal discussions with physicians
suggest that they may not consider this as a limitation to reduce the number of tests ordered ini-
tially and proceeding sequentially based on individual patient requirement and test results.
In conclusion, our initial results showed that hospital-based committees including labora-
tory professionals and clinicians can define hospital based problems and can lead to a stan-
dardized approach to test use that can help clinicians considerably reduce laboratory costs
through appropriate use of the laboratory tests. In addition, hospital based health technology
assessment unit provides a structured ground for such collaborative work.
Fig 2. Total number of laboratory tests moved to the second page per month.
doi:10.1371/journal.pone.0153693.g002
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